Geldanamycin, radicicol, and chimeric inhibitors of the Hsp90 N-terminal ATP binding site.
about
Glial cell line-derived neurotrophic factor reverses ethanol-mediated increases in tyrosine hydroxylase immunoreactivity via altering the activity of heat shock protein 90Tumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategiesGambogic acid identifies an isoform-specific druggable pocket in the middle domain of Hsp90βIdentification of rab20 as a potential regulator of connexin 43 trafficking.Synthesis and evaluation of Hsp90 inhibitors that contain the 1,4-naphthoquinone scaffold.A high-throughput TNP-ATP displacement assay for screening inhibitors of ATP-binding in bacterial histidine kinasesAAV exploits subcellular stress associated with inflammation, endoplasmic reticulum expansion, and misfolded proteins in models of cystic fibrosis.Molecular chaperones and regulation of tau quality control: strategies for drug discovery in tauopathies.Heat shock response and insulin-associated neurodegeneration.A systematic protocol for the characterization of Hsp90 modulators.Helicases as prospective targets for anti-cancer therapy.Natural product inhibitors of Hsp90: potential leads for drug discoveryDesign, synthesis, and biological evaluation of conformationally constrained cis-amide Hsp90 inhibitors.Alternate strategies of Hsp90 modulation for the treatment of cancer and other diseases.Targeting the molecular chaperone SlyD to inhibit bacterial growth with a small molecule.Hsp90 inhibition: elimination of shock and stress.Natural Product Inspired N-Terminal Hsp90 Inhibitors: From Bench to Bedside?Alternative approaches to Hsp90 modulation for the treatment of cancer.Chemical proteomics-driven discovery of oleocanthal as an Hsp90 inhibitor.Heat shock proteins and kidney disease: perspectives of HSP therapy.Can hsp90alpha-targeted siRNA combined with TMZ be a future therapy for glioma?Pink1 Parkinson mutations, the Cdc37/Hsp90 chaperones and Parkin all influence the maturation or subcellular distribution of Pink1.Choice of biological source material supersedes oxidative stress in its influence on DJ-1 in vivo interactions with Hsp90.A highly selective Hsp90 affinity chromatography resin with a cleavable linker.Novobiocin Analogues That Inhibit the MAPK Pathway.Heat shock protein 90 (hsp90) expression and breast cancer.Metal-Free Direct Amidation of Naphthoquinones Using Hydroxamic Acids as an Amide Source: Application in the Synthesis of an HDAC6 Inhibitor.Could Upregulated Hsp70 Protein Compensate for the Hsp90-Silence-Induced Cell Death in Glioma Cells?
P2860
Q24311534-BBDF9961-EE0B-4286-B963-B2275F5BEADEQ28085631-212C193E-71E3-4BE9-A888-29611AA747FDQ28829208-82000D42-F459-4808-A37A-42CB86EBB60BQ33354230-C42B76A4-70DF-4330-A0C5-CEBD0B5F87B5Q33394883-5D4FFABB-532E-4E84-82B9-EA8A532E0674Q33738068-6EA9EADB-D730-4148-92B1-A57C2503C1A8Q33916501-B503AB35-4EE7-4742-B66C-39EB60C7B888Q35313148-F1A6B741-2D8F-4B89-AC77-5EDFCB035B38Q35870561-263E2E94-20F0-4BE3-A1FF-2D67793F839EQ36201554-D6FDC6E3-1343-49CA-9D6A-7C15D7B92F86Q36930862-9B92F117-C2C8-4DF5-9AEB-16F5200A1B42Q37136710-31843388-27AC-43DF-B97E-5F07E5579D6CQ37230641-338987F4-6346-4E3D-9D4A-FD0FDC83C2ABQ37622446-38779F18-5D79-494E-994C-C25569E996FCQ37630656-7CD2AFFF-E2CD-4699-BDEB-214653E64F8EQ38291354-96A26D26-68A6-4158-B94D-984767A0A77DQ38502737-E86F1A00-FB6E-44BD-8042-E5950185ECCCQ39103704-68B32276-1F4A-4442-8E76-4B893C77FE27Q39148082-10A17268-4762-4618-9F40-63AC7794DF2FQ39242393-FD3A8E42-BC45-45BA-9146-59EC7C230EDBQ39731113-CF538CF9-2874-4B53-9498-094E15D2A954Q40051916-344F2060-B083-4658-B643-FAEB31F83D9AQ40987726-A3938C19-B6E2-4D16-AF7C-5C8D28314E0DQ42149303-E176BAC8-1BDC-4839-A536-7E2D8B820E49Q42245370-8E25190C-AB2A-4127-B8E7-0B473C36A7BDQ42922811-9A79BC62-BFE7-4AB7-85A4-482B9138085DQ43025273-67E40D7E-250C-4293-BE95-80451B0F6BDDQ59050553-F186407E-A4B4-44AA-8110-0FC5357F86E6
P2860
Geldanamycin, radicicol, and chimeric inhibitors of the Hsp90 N-terminal ATP binding site.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Geldanamycin, radicicol, and c ...... 0 N-terminal ATP binding site.
@ast
Geldanamycin, radicicol, and c ...... 0 N-terminal ATP binding site.
@en
Geldanamycin, radicicol, and c ...... 0 N-terminal ATP binding site.
@nl
type
label
Geldanamycin, radicicol, and c ...... 0 N-terminal ATP binding site.
@ast
Geldanamycin, radicicol, and c ...... 0 N-terminal ATP binding site.
@en
Geldanamycin, radicicol, and c ...... 0 N-terminal ATP binding site.
@nl
prefLabel
Geldanamycin, radicicol, and c ...... 0 N-terminal ATP binding site.
@ast
Geldanamycin, radicicol, and c ...... 0 N-terminal ATP binding site.
@en
Geldanamycin, radicicol, and c ...... 0 N-terminal ATP binding site.
@nl
P2093
P1476
Geldanamycin, radicicol, and c ...... 0 N-terminal ATP binding site.
@en
P2093
Brian S J Blagg
Donna J Lubbers
M Kyle Hadden
P304
P356
10.2174/156802606777812031
P577
2006-01-01T00:00:00Z